Ariel BlogThe Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.
The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.
ArielDx® Pancreatitis uses information from genetic testing, your health records, and environmental exposures to provide a personalized guide for your care. Our goal is to minimize disease effects and maximize health and quality of life.
 Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.&picture=https://arielmedicine.com/wp-content/uploads/2020/05/study-dna-b-150x150.jpg&description=The Common Chymotrypsinogen C (CTRC) Variant G60G (C.180T) Increases Risk of Chronic Pancreatitis But Not Recurrent Acute Pancreatitis in a North American Population.)
